Trials / Terminated
TerminatedNCT01384409
A Phase 3 Clinical Study of KW-3357 in Patients With DIC
A Clinical Study of KW-3357 in Patients Diagnosed as Disseminated Intravascular Coagulation (DIC) by Japanese Association for Acute Medicine-defined DIC Criteria
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Kyowa Kirin Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and safety of KW-3357 with concomitant use of heparin using multi-center, non-comparative, open-label method in patients diagnosed as disseminated intravascular coagulation (DIC) by Japanese Association for Acute Medicine-defined DIC criteria.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KW-3357 | Intravenous infusion once a day |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2012-10-01
- Completion
- 2012-10-01
- First posted
- 2011-06-29
- Last updated
- 2017-03-24
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01384409. Inclusion in this directory is not an endorsement.